NIAID Radiation/Nuclear Medical Countermeasure Product Development Support

Sponsor Deadline: 

Sep 21, 2019

Letter of Intent Deadline: 

Aug 19, 2019

Sponsor: 

NIH National Institute of Allergy and Infectious Diseases

UI Contact: 

NIAID Radiation/Nuclear Medical Countermeasure Product Development Support

RFP NIAID-DAIT-NIHAI201800019
Presolicitation  https://www.fbo.gov/index?s=opportunity&mode=form&id=356f7905f056d75458e...
ans  Sources Sought  https://www.fbo.gov/index?s=opportunity&mode=form&id=9a60a7d72f7172ed64c...

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases.  The NIAID, Division of Allergy, Immunology and Transplantation (DAIT) has a requirement for advanced product development by the Biomedical Advanced Research and Development Authority or acquisition under the Project BioShield Act of 2004.

Categories: